Netherlands Diabetes Market will be USD 4.48 Billion by 2025

1
Netherlands Diabetes Market
Netherlands Diabetes Market
2
Netherlands Diabetes Market
According to the latest report by Renub Research,
titled "Netherlands Diabetes Market, By Blood
Glucose (SMBG) Device, Continuous Glucose
Monitoring (CGM), Insulin Pen, Insulin Pump,
Reimbursement Company Analysis Forecast" The
prevalence of diabetes mellitus (DM) is
proliferating in the Netherlands. Countrys
diabetes care is largely focused on primary
health care, with the responsibility of general
practitioners for most areas of care. The rise in
the prevalence of obesity is another point of
concern, leading to a vast increase in the number
of patients with metabolic syndrome. According to
Renub Research analysis, Netherlands Diabetes
Market is forecasted to reach USD 4.48 Billion by
the year 2025.
Netherlands Diabetes Market
3
Netherlands Diabetes Market
During the last decade, the Netherlands has seen
an increase in the incidence of type 2 diabetes.
Almost half the Netherlands population suffered
from at least one chronic illness in the last
decade. Diabetes mellitus is one of the diseases
with a high burden of disease and a decrease in
the quality of life in the country. But the good
news is that with the ageing of the Dutch
population and the prevalence of obesity as a
significant risk factor for diabetes, the
survival rate is improving. As many screening
programs are being introduced in the Netherlands.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lnetherlands-diabetes-market-p.php
Netherlands Diabetes Market
4
Netherlands Diabetes Market
Netherlands has implemented the National Action
program Diabetes (NAD) in the last decade to
fight against diabetes. It was aimed to use a
specific implementation plan to introduce the
Care Standard (CS) for diabetes and to pilot it
in several regions. Roche received the CE Mark
for its Accu-Chek Sugar View app in December
2019. Accu-Chek Sugar View is the first app that
checks blood glucose ranges without the need for
a blood glucose meter by taking pictures with a
smartphone camera. The impact of COVID-19 on
Netherlands Diabetes Market The spending on
healthcare has increased in the nation due to
this the market for diabetes management will also
increase according to Renub Research analysis.
This research report covers the impact of
coronavirus on the diabetic market of the
Netherlands.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlnetherlands-diabetes-market-p.php
Netherlands Diabetes Market
5
Netherlands Diabetes Market
Market Summary By CGM  The market and market
share of CGM Market by Components, Glucose
Sensor, Transmitter, CGM User, Reimbursement are
covered in this research report. By Self
Monitoring Blood Glucose Device  SMBG Market by
Test Strips, Lancet, Meter, Blood Glucose Device
Users Reimbursement are given in the
report. By Insulin Pen The number of Insulin
Pen Users, Types Disposable, Reusable and Smart
Insulin Pen, Insulin Pen Needle Market,
Reimbursement Policies are covered in this
research report. By Insulin Pump  This research
report covers Insulin Pump Users, Market
Differentiation Points of Insulin Pump Products,
Training Model for Patients HCP, Reimbursement
Policies. By Company  This research report has
covered Company overview, recent developments/
initiatives and revenue analysis for B. Braun
Melsungen AG, Eli Lilly and Company, Artsana
S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd,
Ypsomed AG, Medtronic, Insulet Corporation,
LifeScan Inc., Abbott Laboratories, DexcomInc and
Roche.
Netherlands Diabetes Market
6
Netherlands Diabetes Market
Netherlands Diabetes Market
7
Contact Us
Netherlands Diabetes Market